TITLE
Rheumatoid arthritis and response to anti-TNF alpha therapy: blood

SUMMARY
Analysis of whole blood from rheumatoid arthritis patients at baseline of infliximab therapy. Infliximab is an anti-TNF alpha antibody. Clinical response to infliximab determined at week 14 of therapy. Results identify a gene expression signature for predicting the response to infliximab.

ORGANISM
Homo sapiens

